Cardinal Health Opens Distribution Center In Texas, Plans One In California

The new Texas facility will ship approximately 10,000 packages containing critical medical supplies daily directly to people's homes nationwide.
In this photo illustration, the logo of Cardinal Health is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)
In this photo illustration, the logo of Cardinal Health is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)
Profile Image
Anan Ashraf·Stocktwits
Updated Sep 04, 2025   |   12:48 PM GMT-04
Share
·
Add us onAdd us on Google

Cardinal Health (CAH) announced on Thursday the opening of a new distribution center in Fort Worth, Texas, and stated that it will also break ground on a new distribution center in Sacramento, California, this fiscal year.

On Stocktwits, retail sentiment around CAH stock stayed within ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.

The new 340,000 square foot Texas facility marks the company’s third distribution center built from the ground up in just three years, the company said, while adding that it will ship approximately 10,000 packages containing critical medical supplies per day directly to people's homes across the country.  The supplies will help manage conditions like diabetes, sleep apnea, and urological conditions, the firm added.

The facility is dedicated to the company’s At-Home Solutions business, similar to its buildings in Ohio and South Carolina. The firm also stated that it will break ground on another new site fully dedicated to the at-Home Solutions business in Sacramento this fiscal year. The new Sacramento building is anticipated to be fully operational in summer 2027.

Last month, Cardinal Health reported fourth-quarter revenue of $60.2 billion, up from $59.9 billion reported in the corresponding quarter of 2024 and adjusted earnings per share of $2.08, marking a growth of 13% year-on-year.

The pharmaceutical and specialty solutions segment, as well as the global medical products and distribution segment, accounted for the majority of the company’s revenue during the period. CAH stock is up 26% this year and approximately 31% over the past 12 months. 

Also See: Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share
·
Add us onAdd us on Google
Read about our editorial guidelines and ethics policy